FBRX - CIK 0001419041
Forte Biosciences, Inc. (FBRX) reported revenue of $36.00K for fiscal year 2019, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2019 | $36.00K | -99.8% |
| FY 2018 | $18.04M | +43890.2% |
| FY 2017 | $41.00K | -16.3% |
| FY 2016 | $49.00K | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.